Your selections:
ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.
- Lozinski, Mathew, Bowden, Nikola A., Graves, Moira C., Fay, Michael, Day, Bryan W., Stringer, Brett W., Tooney, Paul A.
Comparison between [⁶⁸Ga]Ga-PSMA-617 and [¹⁸F]FET PET as Imaging Biomarkers in Adult Recurrent Glioblastoma
- Brighi, Caterina, Puttick, Simon, Woods, Amanda, Keall, Paul, Tooney, Paul A., Waddington, David E. J., Sproule, Vicki, Rose, Stephen, Fay, Michael
Vasculogenic Mimicry Occurs at Low Levels in Primary and Recurrent Glioblastoma
- Maddison, Kelsey, Faulkner, Sam, Graves, Moira C., Fay, Michael, Bowden, Nikola A., Tooney, Paul A.
A novel semiautomated method for background activity and biological tumour volume definition to improve standardisation of ¹⁸F-FET PET imaging in glioblastoma
- Brighi, Caterina, Puttick, Simon, Li, Shenpeng, Keall, Paul, Neville, Katherine, Waddington, David, Bourgeat, Pierrick, Gillman, Ashley, Fay, Michael
- Lozinski, Mathew, Bowden, Nikola A., Graves, Moira C., Fay, Michael, Day, Bryan W., Stringer, Brett W., Tooney, Paul A.
- Lozinski, Mathew, Bowden, Nikola A., Graves, Moira C., Fay, Michael, Tooney, Paul A.
Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma
- Maddison, Kelsey, Graves, Moira C., Bowden, Nikola A., Fay, Michael, Vilain, Ricardo E., Faulkner, Sam, Tooney, Paul A.
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients
- Climans, Seth A., Brandes, Alba A., Phillips, Claire, Roa, Wilson, Wick, Wolfgang, Winch, Chad, Mason, Warren P., Cairncross, J. Gregory, Ding, Keyue, Fay, Michael, Laperriere, Normand, Menten, Johan, Nishikawa, Ryo, O'Callaghan, Christopher J., Perry, James R.
Exploring positive survivorship experiences of indigenous Australian cancer patients
- Tam, Laura, Garvey, Gail, Meiklejohn, Judith, Martin, Jennifer, Adams, Jon, Walpole, Euan, Fay, Michael, Valery, Patricia
Short-course radiation plus temozolomide in elderly patients with glioblastoma
- Perry, James R., Laperriere, Normand, Osoba, David, Rossiter, John P., Sahgal, Arjun, Hirte, Hal, Laigle-Donadey, Florence, Franceschi, Enrico, Chinot, Olivier, Golfinopoulos, Vassilis, Fariselli, Laura, Wick, Antje, O'Callaghan, Christopher J., Brandes, Alba A., Menten, Johan, Phillips, Claire, Fay, Michael, Nishikawa, Ryo, Cairncross, J. Gregory, Roa, Wilson
- Cheng, Matthew, Fay, Michael, Steinke, Karin
- Lindsay, Julian, Dooley, Michael, Martin, Jennifer, Fay, Michael, Kearney, Alison, Khatun, Mohsina, Barras, Michael
- Hosein, Abdel Nasser, Lim, Yi Chieh, Day, Bryan, Stringer, Brett, Rose, Stephen, Head, Richard, Cosgrove, Leah, Sminia, Peter, Fay, Michael, Martin, Jennifer H.
Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method
- Rundle-Thiele, Dayle, Day, Bryan, Coulthard, Alan, Crozier, Stuart, Rose, Stephen, Stringer, Brett, Fay, Michael, Martin, Jennifer, Jeffree, Rosalind L., Thomas, Paul, Bell, Christopher, Salvado, Oliver, Gal, Yaniv
Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?
- Fay, Michael, Head, Richard, Martin, Jennifer
Are you sure you would like to clear your session, including search history and login status?